Controversy over new Alzheimer's drug

Controversy over new Alzheimer's drug

The first Alzheimer's drug to the market in 20 years is being dogged by controversy, as the Cleveland Clinic and New York's Mount Sinai hospital, along with a handful of insurance companies say they will not cover it.

Top Stories